Immune cell attack: new hope for tough melanoma?
NCT ID NCT07288203
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tests a personalized cell therapy called lifileucel (TIL) for people with advanced melanoma that has not responded to standard treatments. About 100 adults with stage III or IV melanoma will receive their own immune cells that have been specially grown in a lab to fight the cancer. The goal is to see if this treatment can shrink tumors and control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de l'Universite de Montreal
Montral, Quebec, Canada, H2X 0A9, Canada
-
Greenslopes Private Hospital
Greenslopes, Queensland, 4120, Australia
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9, Canada
-
Royal Marsden Hospital
London, SW3 6JJ, United Kingdom
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.